XML 15 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Investments:    
Fixed maturity securities available for sale, at fair value (net of allowances for credit losses of $2.8 and $1.9 at March 31, 2026 and December 31, 2025, respectively; amortized cost - $8,956.7 and $8,635.3 at March 31, 2026 and December 31, 2025, respectively) $ 8,783.8 $ 8,577.7
Equity securities at fair value 197.3 207.1
Commercial mortgage loans on real estate, at amortized cost (net of allowances for credit losses of $6.3 and $6.7 at March 31, 2026 and December 31, 2025, respectively) 309.5 324.7
Short-term investments 329.8 379.5
Other investments 601.5 573.0
Total investments 10,221.9 10,062.0
Cash and cash equivalents 1,591.7 1,834.1
Premiums and accounts receivable (net of allowances for credit losses of $12.4 and $10.4 at March 31, 2026 and December 31, 2025, respectively) 2,025.3 1,989.4
Reinsurance recoverables (net of allowances for credit losses of $5.2 at March 31, 2026 and December 31, 2025) 6,542.0 6,471.3
Accrued investment income 118.7 135.4
Deferred acquisition costs 10,201.4 10,187.6
Property and equipment, net 848.9 841.7
Goodwill 2,654.5 2,646.3
Other intangible assets, net 511.1 522.0
Other assets (net of allowances for credit losses of $0.9 at March 31, 2026 and December 31, 2025) 1,053.0 1,087.4
Assets held for sale (Note 4) 0.0 512.4
Total assets 35,768.5 36,289.6
Liabilities    
Future policy benefits and expenses 54.7 55.7
Unearned premiums 20,902.7 20,881.4
Claims and benefits payable 2,168.6 2,101.2
Commissions payable 606.0 640.6
Funds held under reinsurance 287.1 266.4
Accounts payable and other liabilities (including allowances for credit losses of $0.7 and $0.9 at March 31, 2026 and December 31, 2025, respectively, for the unsecured portion of the high deductible recoverables) 3,672.5 3,766.3
Debt 2,207.5 2,206.9
Liabilities held for sale (Note 4) 0.0 499.5
Total liabilities 29,899.1 30,418.0
Commitments and contingencies (Note 14)
Stockholders’ equity    
Common stock, par value $0.01 per share, 800,000,000 shares authorized, 51,967,256 and 52,089,008 shares issued and 49,671,167 and 49,792,919 shares outstanding at March 31, 2026 and December 31, 2025, respectively 0.5 0.5
Additional paid-in capital 1,671.4 1,711.8
Retained earnings 4,949.3 4,826.3
Accumulated other comprehensive loss (629.0) (544.2)
Treasury stock, at cost; 2,296,089 shares at March 31, 2026 and December 31, 2025 (122.8) (122.8)
Total stockholders’ equity 5,869.4 5,871.6
Total liabilities and stockholders’ equity $ 35,768.5 $ 36,289.6